ClassID:

20065

A61K9/1271 - page 3 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Recent Application in this class:
#601
20210206846
2021-07-08

METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES

#602
20210205456
2021-07-08

Targeted liposomes

#603
20210205293
2021-07-08

COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER

#604
20210205229
2021-07-08

MICROENCAPSULATED MODIFIED POLYNUCLEOTIDE COMPOSITIONS AND METHODS

#605
20210205219
2021-07-08

Stabilizing camptothecin pharmaceutical compositions

#606
20210205218
2021-07-08

Hybrid biological membranes, methods of making and uses thereof

#607
20210196632
2021-07-01

MODIFIED PLANT MESSENGER PACKS AND USES THEREOF

#608
20210189397
2021-06-24

SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY

#609
20210187120
2021-06-24

Peptide-nanoparticle conjugates

#610
20210186894
2021-06-24

IPA-3-loaded liposomes and methods of use thereof

#611
20210186877
2021-06-24

Methods for production of MSC-derived exosomes

#612
20210177890
2021-06-17

COMPOSITION CONTAINING CHLORINE DIOXIDE AND METHODS FOR USING SAME

#613
20210177756
2021-06-17

Nanotube-vesicle compositions and uses thereof

#614
20210170054
2021-06-10

NOBLE METAL-COATED MECHANORESPONSIVE VESICLES

#615
20210169887
2021-06-10

Alpha polyglutamated methotrexate and uses thereof

#616
20210163418
2021-06-03

Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof

#617
20210162068
2021-06-03

Treatment of primary ciliary dyskinesia with synthetic messenger RNA

#618
20210161899
2021-06-03

Gamma polyglutamated pemetrexed and uses thereof

#619
20210161817
2021-06-03

Therapeutic agents specifically delivered by exosomes for cancer treatment

#620
20210154196
2021-05-27

Gamma polyglutamated methotrexate and uses thereof

#621
20210154140
2021-05-27

Targeted liposomal gemcitabine and methods thereof

#622
20210145746
2021-05-20

Methods for making giant vesicles and their use

#623
20210138089
2021-05-13

Nanoallergens and uses thereof

#624
20210137914
2021-05-13

Liposomes Useful for Drug Delivery

#625
20210137839
2021-05-13

COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY

#626
20210137838
2021-05-13

LIPID-BASED NANOPARTICLES WITH ENHANCED STABILITY

#627
20210128489
2021-05-06

GM3 functionalized nanoparticles

#628
20210128485
2021-05-06

NANOPARTICLES FOR GENE EXPRESSION AND USES THEREOF

#629
20210128471
2021-05-06

Liposome composition and method for producing the same

#630
20210128470
2021-05-06

Method for treating a metabolite toxicopathy

#631
20210128469
2021-05-06

Gamma polyglutamated tetrahydrofolates and uses thereof

#632
20210115101
2021-04-22

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#633
20210113465
2021-04-22

Systems and methods for targeted breast cancer therapies

#634
20210113455
2021-04-22

Encapsulation of microbubbles within the aqueous core of microcapsules

#635
20210106529
2021-04-15

Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same

#636
20210101875
2021-04-08

Aminoalcohol lipidoids and uses thereof

#637
20210100791
2021-04-08

Combined pharmaceutical formulation comprising drug-containing liposome composition and immune checkpoint inhibitor

#638
20210093721
2021-04-01

COLLOIDAL PARTICLES FOR USE IN MEDICINE

#639
20210085744
2021-03-25

Edible plant-derived nanoparticles for regulation of gut microbiota

#640
20210085615
2021-03-25

BIOMOLECULAR COMPOSITES COMPRISING MODIFIED CELL GHOSTS

#641
20210077634
2021-03-18

IN VIVO PRODUCTION OF PROTEINS

#642
20210077449
2021-03-18

Formulations Having Anti-inflammatory Activity and Antimicrobial Activity Against Gram-Positive Bacteria

#643
20210077400
2021-03-18

Prodrug compositions, prodrug nanoparticles, and methods of use thereof

#644
20210060177
2021-03-04

Lipid nanoparticle compositions and methods for mRNA delivery

#645
20210054412
2021-02-25

Nano-vesicles derived from genus bacteria and use thereof

#646
20210052592
2021-02-25

Alpha polyglutamated aminopterin and uses thereof

#647
20210052497
2021-02-25

Liposomal particles, methods of making same and uses thereof

#648
20210052496
2021-02-25

Anionic nanocomplexes for nucleic acid delivery

#649
20210038719
2021-02-11

Alpha polyglutamated antifolates and uses thereof

#650
20210038641
2021-02-11

Method for Producing an Exosome Containing Agent for Metastasis Suppression

#651
20210038519
2021-02-11

Lipid-derived neutral nanoparticles

#652
20210030678
2021-02-04

CANNABINOID AND CBD LIPOSOME FORMULATIONS AND USES THEREOF

#653
20210030675
2021-02-04

MESOPOROUS SILICA NANOPARTICLES AND SUPPORTED LIPID BI-LAYER NANOPARTICLES FOR BIOMEDICAL APPLICATIONS

#654
20210023556
2021-01-28

Limit size lipid nanoparticles and related methods

#655
20210023023
2021-01-28

LIPOSOMAL NUTRACEUTICAL COMPOSITIONS AND METHODS OF MAKING THE SAME

#656
20210023006
2021-01-28

Gamma polyglutamated raltitrexed and uses thereof

#657
20210023005
2021-01-28

CANNABINOID-CONTAINING COMPOSITIONS IN THE FORM OF SPHERES OR SPHERE-LIKE PARTICLES, METHODS FOR THEIR PREPARATION, AND THERAPEUTIC APPLICATIONS

#658
20210023004
2021-01-28

Liposome composition

#659
20210015758
2021-01-21

Modular Particulars for Immunotherapy

#660
20210009503
2021-01-14

Ionizable cationic lipids

#661
20210008091
2021-01-14

Remote loading of sparingly water-soluble drugs into lipid vesicles

#662
20210007988
2021-01-14

IMMUNO-EXOSOMES AND METHODS OF USE THEREOF

#663
20200405641
2020-12-31

Lipid-based coating composition, and an object having a lipid-based coating

#664
20200405640
2020-12-31

Synthetic extracellular vesicles for novel therapies

#665
20200405639
2020-12-31

NOVEL DELIVERY OF LARGE PAYLOADS

#666
20200399247
2020-12-24

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

#667
20200397698
2020-12-24

Fusogenic liposome-coated porous silicon nanoparticles

#668
20200390797
2020-12-17

Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations

#669
20200390794
2020-12-17

Targeted intracellular delivery of antiviral agents

#670
20200390718
2020-12-17

METHODS AND COMPOSITIONS FOR ATTENUATED ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSE

#671
20200390702
2020-12-17

LIPOSOMAL TAXANES FOR TREATMENT OF SCLC

#672
20200376108
2020-12-03

Comprehensive vaccine design for commensal disease progression

#673
20200376078
2020-12-03

Compositions of phosphorylated tau peptides and uses thereof

#674
20200368359
2020-11-26

Reduced and oxidized polysaccharides and methods of use thereof

#675
20200368162
2020-11-26

Nucleic Acid-Based Therapy of Muscular Dystrophies

#676
20200360510
2020-11-19

FORMULATIONS FOR VIROSOMES

#677
20200360390
2020-11-19

Alpha polyglutamated pralatrexate and uses thereof

#678
20200360388
2020-11-19

Alpha polyglutamated pemetrexed and uses thereof

#679
20200360367
2020-11-19

Treatment of Breast Cancer with Liposomal Irinotecan

#680
20200360289
2020-11-19

FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION

#681
20200354423
2020-11-12

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

#682
20200352859
2020-11-12

Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal

#683
20200345825
2020-11-05

FORMULATION OF FISH VACCINE BASED ON LIPIDIC NANOVESICLES, IN PARTICULAR, A PROTEOLIPOSOME OR COCHLEATE, WITH ACTIVITY AGAINST THE SALMONID RICKETTSIAL SYNDROME (SRS)

#684
20200345641
2020-11-05

Lipid nanoparticles

#685
20200345639
2020-11-05

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#686
20200339643
2020-10-29

Heterologous administration of tau vaccines

#687
20200338214
2020-10-29

Lipid nanoparticle compositions and methods for mRNA delivery

#688
20200338003
2020-10-29

Treating microvascular dysfunction

#689
20200330599
2020-10-22

Liposomal system for drug delivery

#690
20200330569
2020-10-22

Peptide conjugated particles

#691
20200330432
2020-10-22

THERAPEUTICS FOR PRETERM LABOR MANAGEMENT

#692
20200316146
2020-10-08

Synthetically enveloped virus

#693
20200315967
2020-10-08

LIPID NANOPARTICLES

#694
20200306188
2020-10-01

In vivo targeting of extracellular vesicles

#695
20200297870
2020-09-24

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

#696
20200297867
2020-09-24

SURFACE FUNCTIONALIZATION OF LIPOSOMES AND LIPOSOMAL SPHERICAL NUCLEIC ACIDS (SNAS)

#697
20200297633
2020-09-24

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

#698
20200297632
2020-09-24

Delivery of agents to inflamed tissues using folate-targeted liposomes

#699
20200289652
2020-09-17

Drug delivery system containing phospholipid and cholesterol

#700
20200289639
2020-09-17

Chikungunya virus RNA vaccines

#701
20200289638
2020-09-17

Zika virus RNA vaccines

#702
20200289417
2020-09-17

Delivery method of target material into extracellular vesicles using extracorporeal shockwave

#703
20200281950
2020-09-10

LIPOSOMES FOR TREATMENT OF AN AUTOIMMUNE DISEASE

#704
20200270217
2020-08-27

Biodegradable compound, lipid particle, composition comprising lipid particle, and kit

#705
20200268742
2020-08-27

Combination Therapy for Cancer Treatment

#706
20200268665
2020-08-27

COMPOSITIONS AND METHODS FOR CANCER TREATMENT

#707
20200268664
2020-08-27

LIPOSOMAL APPARATUS AND MANUFACTURING METHODS

#708
20200261363
2020-08-20

LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL

#709
20200254107
2020-08-13

Use of high molecular weight polyethylene glycol compositions to restore the efficacy of pegylated therapeutic compositions

#710
20200253873
2020-08-13

Method of safe administration of phosphorylated tau peptide vaccine

#711
20200253872
2020-08-13

Liposome compositions and methods of use thereof

#712
20200253871
2020-08-13

LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS IN HUMANS

#713
20200253870
2020-08-13

A LDV LIPOSOMAL FORMULATION OF PHOTO SYSTEM-I FOR TREATMENT OF CANCER

#714
20200247861
2020-08-06

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

#715
20200246266
2020-08-06

Pharmaceutical preparation of carbohydrates for therapeutic use

#716
20200246265
2020-08-06

LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES

#717
20200237671
2020-07-30

Cleavable lipids

#718
20200230058
2020-07-23

Pegylated liposomes for delivery of immunogen-encoding RNA

#719
20200224193
2020-07-16

METHOD OF MANUFACTURING VESICLES BY DELIVERY OF RNA NANOPARTICLES AND VESICLES MANUFACTURED USING THE SAME

#720
20200222324
2020-07-16

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

#721
20200222323
2020-07-16

ADRENALIN-CONTAINING DOUBLE LAYERED LIPID VESICLES FOR USE IN THE TREATMENT OF CARDIAC EMERGENCIES

#722
20200214988
2020-07-09

Multisomes: encapsulated droplet networks

#723
20200214980
2020-07-09

NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS

#724
20200206362
2020-07-02

Compositions and methods for delivery of agents

#725
20200206143
2020-07-02

Platelets loaded with anti-cancer agents

#726
20200206135
2020-07-02

INSTANT THICKENED DRY FOOD COMPOSITIONS

#727
20200199592
2020-06-25

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

#728
20200199064
2020-06-25

Cationic lipids for therapeutic agent delivery formulations

#729
20200197424
2020-06-25

Long-circulating liposome modified with c(RGD-ACP-K)

#730
20200188513
2020-06-18

Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections

#731
20200188300
2020-06-18

Formulation comprising liposomes

#732
20200179371
2020-06-11

Stabilizing Camptothecin Pharmaceutical Compositions

#733
20200179341
2020-06-11

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE MYELOMA AND INCREASING ANTIBODY DEPENDENT CELL CYTOTOXICITY BY TARGETING THE ARYL HYDROCARBON RECEPTOR

#734
20200179284
2020-06-11

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

#735
20200179283
2020-06-11

Nanolipogel vehicles for controlled delivery of different pharmaceutical agents

#736
20200171080
2020-06-04

Liposomes for drug delivery and methods for preparation thereof

#737
20200165353
2020-05-28

ANTI-CD22 ANTIGEN BINDING MOLECULES TO TREAT LUNG CANCER AND PROSTATE CANCER

#738
20200164091
2020-05-28

Mesothelioma Gene Therapy

#739
20200164038
2020-05-28

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#740
20200163898
2020-05-28

PEGylated lipid nanoparticle with bioactive lipophilic compound

#741
20200163877
2020-05-28

Liposome formulations

#742
20200157205
2020-05-21

Methods and compositions for delivering MRNA coded antibodies

#743
20200155706
2020-05-21

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#744
20200155671
2020-05-21

Particles comprising a shell with RNA

#745
20200155454
2020-05-21

Polymer-grafted nanobins

#746
20200147161
2020-05-14

HLA-restricted VCX/Y peptides and T cell receptors and use thereof

#747
20200138868
2020-05-07

Compositions for Drug Delivery and Methods of Use Thereof

#748
20200138715
2020-05-07

PEGylated liposomes and methods of use

#749
20200131516
2020-04-30

Molecules and agents for treating hepatitis B virus

#750
20200129434
2020-04-30

LIPOSOME COMPOSITIONS AND USES THEREOF

#751
20200129433
2020-04-30

Stem cell-derived microvesicles with enhanced efficacy, use thereof, and method for enhancing efficacy

#752
20200129432
2020-04-30

Polynucleotide encapsulation and preservation using self-assembling membranes

#753
20200123575
2020-04-23

Molecular system for cancer biology

#754
20200123100
2020-04-23

Compounds and compositions for intracellular delivery of therapeutic agents

#755
20200121724
2020-04-23

Compositions and methods for glaucoma

#756
20200121723
2020-04-23

Use of composition comprising exosome derived from adipose-derived stem cell as effective ingredient in ameliorating dermatitis

#757
20200113943
2020-04-16

METHODS FOR ENHANCED PRODUCTION AND ISOLATION OF CELL-DERIVED VESICLES AND TREATMENT OF INFLAMMATION AND NEUROLOGICAL DAMAGE

#758
20200113832
2020-04-16

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

#759
20200113830
2020-04-16

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

#760
20200109420
2020-04-09

Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins

#761
20200109419
2020-04-09

Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein

#762
20200109183
2020-04-09

Extracellular vesicle comprising a fusion protein having Fc binding capacity

#763
20200101016
2020-04-02

COMPOSITIONS AND METHODS FOR PRODUCING EXOSOME LOADED THERAPEUTICS FOR TREATING CARDIOVASCULAR DISEASE

#764
20200093742
2020-03-26

Combination HIV therapeutic

#765
20200086289
2020-03-19

METHODS AND DEVICES FOR LIPOSOME PREPARATION BY CENTRIFUGATION

#766
20200085973
2020-03-19

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

#767
20200085875
2020-03-19

PLATELET VESICLE-ENGINEERED CELLS FOR TARGETED TISSUE REPAIR

#768
20200085757
2020-03-19

Nanoalum particles comprising a PAA sizing agent

#769
20200085743
2020-03-19

Glucose sensitive compositions for drug delivery

#770
20200085742
2020-03-19

NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS

#771
20200080112
2020-03-12

Crispr enzymes and systems

#772
20200080086
2020-03-12

Cationic lipid

#773
20200069793
2020-03-05

Varicella zoster virus (VZV) vaccine

#774
20200069599
2020-03-05

STABILIZED FORMULATIONS OF LIPID NANOPARTICLES

#775
20200069587
2020-03-05

Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

#776
20200069586
2020-03-05

Stabilizing camptothecin pharmaceutical compositions

#777
20200061220
2020-02-27

Stabilized nanobubbles for diagnostic and therapeutic applications

#778
20200060980
2020-02-27

Compositions for facilitating membrane fusion and uses thereof

#779
20200060970
2020-02-27

Exosome preparation for treating disease and application thereof

#780
20200054557
2020-02-20

Liposomal formulation for use in the treatment of cancer

#781
20200054556
2020-02-20

Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases

#782
20200046766
2020-02-13

CANCER STEM CELL EXOSOMES

#783
20200046753
2020-02-13

Modified pT7/T7 Polymerase System for Sustained shRNA Expression in Cytoplasm and Liposome Transporter Comprising the Same

#784
20200046752
2020-02-13

CFTR MRNA compositions and related methods and uses

#785
20200032293
2020-01-30

NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY KIT, AND NUCLEIC ACID DELIVERY METHOD

#786
20200030416
2020-01-30

Synthetic platelets

#787
20200022922
2020-01-23

Lipid-based nanoparticles and methods using same

#788
20200022914
2020-01-23

LIPOSOMAL COMPOSITIONS AND SOLID ORAL DOSAGE FORMS COMPRISING THE SAME

#789
20200022913
2020-01-23

Liposomal particles, methods of making same and uses thereof

#790
20200017565
2020-01-16

Modified polynucleotides for the production of secreted proteins

#791
20200016181
2020-01-16

Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

#792
20200009050
2020-01-09

Pharmaceutical composition, preparation and uses thereof

#793
20200000722
2020-01-02

Synthetic polypeptides and uses thereof

#794
20190390284
2019-12-26

NANO-VESICLES DERIVED FROM GENUS CUPRIAVIDUS BACTERIA AND USE THEREOF

#795
20190388349
2019-12-26

NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO

#796
20190388348
2019-12-26

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES WITH APELIN

#797
20190388347
2019-12-26

Cell penetrating peptide (CPP)-mediated EV loading

#798
20190381095
2019-12-19

Composition of extracellular vesicles (EVS) and medical uses thereof

#799
20190374654
2019-12-12

Methods and Compositions for Treatment of Interferon-Resistant Tumors

#800
20190367566
2019-12-05

Recombinant polypepties for membrane fusion and uses thereof

#801
20190365921
2019-12-05

Method and System of Harvesting Extracellular Vesicles Using Hydrogel Particles for Later Delivery to, and Remodeling of, an Immune System

#802
20190365660
2019-12-05

Nanocapsules and method for manufacturing thereof

#803
20190365650
2019-12-05

Targeted polymerized nanoparticles for cancer treatment

#804
20190365648
2019-12-05

Synthetic nanostructures including nucleic acids and/or other entities

#805
20190358161
2019-11-28

Hyperstabilized liposomes increase targeting of mitotic cells

#806
20190351071
2019-11-21

STRUCTURES AND METHODS FOR GENE THERAPY

#807
20190350854
2019-11-21

Extracellular vesicles and methods and uses thereof

#808
20190343766
2019-11-14

Medical use of sPLA2 hydrolysable liposomes

#809
20190338051
2019-11-07

PREPARATION METHOD FOR AND USE OF REDOX-RESPONSIVE CHITOSAN-LIPOSOME

#810
20190330657
2019-10-31

Expression constructs, fusogenic lipid-based nanoparticles and methods of use thereof

#811
20190330373
2019-10-31

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

#812
20190328847
2019-10-31

Materials and methods useful for treating glioblastoma

#813
20190328828
2019-10-31

PHARMACEUTICAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, USE OF A PEPTIDE, USE OF A PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DISEASES ASSOCIATED WITH INTRAOCULAR HYPERTENSION OR GLAUCOMA

#814
20190328665
2019-10-31

LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF

#815
20190321489
2019-10-24

Lipid nanoparticle compositions and methods for mRNA delivery

#816
20190321467
2019-10-24

Liposome formulations

#817
20190315824
2019-10-17

Modified polynucleotides for the production of secreted proteins

#818
20190314527
2019-10-17

In vivo production of proteins

#819
20190314394
2019-10-17

IMMUNE-POTENTIATING DRUG NANOCARRIERS AND METHODS OF PRODUCTION AND USE THEREOF

#820
20190314284
2019-10-17

Cleavable lipids

#821
20190314282
2019-10-17

Remote loading of sparingly water-soluble drugs into liposomes

#822
20190307893
2019-10-10

NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE

#823
20190307873
2019-10-10

Pneumococcal vaccine formulations

#824
20190307755
2019-10-10

Polyglutamated antifolates and uses thereof

#825
20190307691
2019-10-10

HYDROGELS WITH LIPOSOMES FOR CONTROLLED RELEASE OF DRUGS

#826
20190307690
2019-10-10

Liposomal Delivery Systems for Oxaliplatin and in Dual Drug Delivery in Combination with Chemo-sensitizing and Chemo-therapeutic agents

#827
20190298755
2019-10-03

Subcutaneous delivery of messenger RNA

#828
20190298658
2019-10-03

Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis

#829
20190290584
2019-09-26

Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

#830
20190284557
2019-09-19

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

#831
20190275170
2019-09-12

Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome

#832
20190269795
2019-09-05

COMPOSITIONS AND METHODS FOR THE MANUFACTURE OF LIPID NANOPARTICLES

#833
20190262441
2019-08-29

Peptide conjugated particles for the treatment of inflammation

#834
20190262331
2019-08-29

Stabilizing Camptothecin Pharmaceutical Compositions

#835
20190255188
2019-08-22

Nanostructures comprising cobalt porphyrin-phospholipid conjugates and polyhistidine-tags

#836
20190255143
2019-08-22

Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH)

#837
20190249197
2019-08-15

Nano-vesicles derived from genus bacteria and use thereof

#838
20190240351
2019-08-08

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

#839
20190240281
2019-08-08

ORAL ANAEROBIC GLUTATHIONE SUPPLEMENT IN LIPOSOME SUSPENSION

#840
20190231704
2019-08-01

COMPOSITIONS FOR ENHANCED UPTAKE BY MACROPHAGES AND METHODS OF USE THEREOF

#841
20190231695
2019-08-01

Compositions and methods for nanoparticle lyophile forms

#842
20190231690
2019-08-01

PLATINUM COMPLEXES AND USES THEREOF

#843
20190224334
2019-07-25

Alpha polyglutamated antifolates and uses thereof

#844
20190224194
2019-07-25

Composition for treating ocular diseases and methods of usage and making

#845
20190224125
2019-07-25

Liposomal compositions and uses of same

#846
20190216932
2019-07-18

Controlled drug release liposome compositions and methods thereof

#847
20190216843
2019-07-18

Synergistic enhancement of the delivery of nucleic acids via blended formulations

#848
20190216736
2019-07-18

SCALE UP SYNTHESIS OF SILICASOME NANOCARRIERS

#849
20190211063
2019-07-11

Pore-forming peptides and uses thereof

#850
20190209651
2019-07-11

Osteoarthritis treatment with chemokine-loaded alginate microparticles

#851
20190209474
2019-07-11

Nanolipogel comprising a polymeric matrix and a lipid shell

#852
20190201545
2019-07-04

Cytotoxic particles for targeting P2X7 receptor

#853
20190201434
2019-07-04

Enhanced immune response in bovine species

#854
20190201372
2019-07-04

LIPOSOMAL PREPARATION AND METHODS OF TREATMENT

#855
20190192690
2019-06-27

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

#856
20190192689
2019-06-27

Lipid nanoparticle compositions and methods for mRNA delivery

#857
20190192664
2019-06-27

COLLOIDAL PARTICLES FOR USE IN MEDICINE

#858
20190192436
2019-06-27

Prodrug compositions, prodrug nanoparticles, and methods of use thereof

#859
20190192435
2019-06-27

Lipid-derived neutral nanoparticles

#860
20190185435
2019-06-20

Stereochemically enriched compositions for delivery of nucleic acids

#861
20190185410
2019-06-20

Ionizable cationic lipids

#862
20190184030
2019-06-20

Delivery of urea to cells of the macula and retina using liposome constructs

#863
20190177347
2019-06-13

Ladderane lipid compounds and liposomes and methods of preparing and using the same

#864
20190177289
2019-06-13

Aminoalcohol lipidoids and uses thereof

#865
20190175761
2019-06-13

Lipid nanoparticle compositions and methods for mRNA delivery

#866
20190167587
2019-06-06

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE INCLUDING MESENCHYMAL STEM CELL-DERIVED ARTIFICIAL NANOSOMES

#867
20190167586
2019-06-06

LIPOSOMAL APPARATUS AND MANUFACTURING METHODS

#868
20190160092
2019-05-30

Advanced Functional Biocompatible Polymeric Matrix Used as a Hemostatic Agent and System for Damaged Tissues and Cells

#869
20190160009
2019-05-30

LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT

#870
20190151461
2019-05-23

Process for formulating an anionic agent

#871
20190151444
2019-05-23

Desensitizing mast cells by co-presentation of antigens with high affinity mast cell siglec ligands

#872
20190151236
2019-05-23

LIPOSOMAL CORTICOSTEROIDS FOR TOPICAL INJECTION IN INFLAMED LESIONS OR AREAS

#873
20190142822
2019-05-16

Treatment of Breast Cancer with Liposomal Irinotecan

#874
20190142751
2019-05-16

Liposomes comprising polymer-conjugated lipids and related uses

#875
20190135789
2019-05-09

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

#876
20190134164
2019-05-09

MRNA therapy for Pompe disease

#877
20190133946
2019-05-09

NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS

#878
20190125895
2019-05-02

Layer-by-layer nanoparticles for cytokine therapy in cancer treatment

#879
20190119357
2019-04-25

MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF

#880
20190119341
2019-04-25

Compositions of phosphorylated tau peptides and uses thereof

#881
20190117798
2019-04-25

Compositions and methods for delivery of agents

#882
20190117644
2019-04-25

Methods for treating pancreatic cancer using combination therapies

#883
20190117643
2019-04-25

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

#884
20190117570
2019-04-25

Use of exosomes for the treatment of disease

#885
20190112423
2019-04-18

Reversibly crosslinked micelle systems

#886
20190111074
2019-04-18

TREATMENT OF PRIMARY CILIARY DYSKINESIA WITH SYNTHETIC MESSENGER RNA

#887
20190111000
2019-04-18

MULTISTAGE DELIVERY OF ACTIVE AGENTS

#888
20190110991
2019-04-18

Remote loading of sparingly water-soluble drugs into liposomes

#889
20190110989
2019-04-18

Systems and methods for targeted breast cancer therapies

#890
20190110988
2019-04-18

Delivery System That Utilizes Liposomal or Emulsion Vehicles

#891
20190105339
2019-04-11

REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES

#892
20190105317
2019-04-11

Stabilizing Camptothecin Pharmaceutical Compositions

#893
20190105271
2019-04-11

Nanoparticle-induced fusogenicity between liposome and endosome membranes for targeted delivery through endosomal escape

#894
20190105270
2019-04-11

LIPOSOME COMPOSITION FOR USE IN PERITONEAL DIALYSIS

#895
20190091257
2019-03-28

Compositions and methods for restoring endothelial glycocalyx

#896
20190091154
2019-03-28

HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES

#897
20190091153
2019-03-28

Preparing method for positively-electrified charged niosome, and charged niosome

#898
20190091152
2019-03-28

USE OF UMIROLIMUS AND ITS DERIVATIVES FOR TREATING CANCER

#899
20190091151
2019-03-28

lipids as broad anti-inflammatory therapeutics and associated methods of use

#900
20190091150
2019-03-28

POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME